Gonorrhea is a sexually transmitted infection that can infect both men and women. Caused by Neisseria gonorrhoeae bacteria, gonorrhea can cause infections in the genitals, rectum and throat. Although treatable, drug-resistant forms of gonorrhea are increasing.
Why Is the Study of Gonorrhea a Priority for NIAID?
If left untreated, gonorrhea can lead to pelvic inflammatory disease, ectopic pregnancy, infertility, and increased risk of HIV infection. Gonorrhea can also be passed from mother to child and cause blindness or life-threatening infections in the infant.
How Is NIAID Addressing This Critical Topic?
NIAID supports a comprehensive, multidisciplinary program of research on Neissesria gonorrhoeae (gonococci).
- Biomedical STI Prevention Evidence Is Inadequate for Cisgender Women
December 20, 2023
- NIH Releases Strategic Plan for Research on Herpes Simplex Virus 1 and 2
September 19, 2023
NIAID Now Blog
Multidrug-Resistant Neisseria gonorrhoeae (Gonorrhea)
Another important area of gonorrhea research concerns antibiotic (drug) resistance. This is particularly important because strains of N. gonorrhoeae that are resistant to recommended antibiotic treatments have been increasing and are becoming widespread in the United States. These events add urgency to conduct research on and develop new antibiotics and to prevent antibiotic resistance from spreading.